Labcorp to spin off clinical-development business
July 28 (Reuters) – Laboratory Corp of America Holdings (LH.N) said on Thursday it would spin off its wholly owned business focused on clinical drug trials, sending its shares up nearly 4%. The planned spin-off will result in two independent, publicly traded companies – Labcorp and the clinical development business, the company said. The clinical-development … Read more